Cited by 357Bladder and Urothelial Cancer TreatmentsGlobal Cancer Incidence and ScreeningUrinary and Genital Oncology Studies

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

The global burden of urinary bladder cancer

Parkin, D. Maxwell·2008·Scandinavian Journal of Urology and Nephrology

DOI 10.1080/03008880802285032

Open this paper in CoChat — free account

Abstract

Statistics on the incidence of bladder cancer are particularly hard to interpret, because of changing classification, variations in counting of multiple cancers in the same individual and, most importantly, the variable inclusion of non-invasive cancers in different data sets. Mortality statistics are almost certainly more comparable, but as indirect estimators of disease risk, require some cautious interpretation, because of differing survival between populations, and over time. Cancer of the bladder is estimated to be the ninth most common cause of cancer worldwide (357 000 cases in 2002) and the 13th most numerous cause of death from cancer (145 000 deaths). Rates in males are three to four times those in females. Incidence rates are high in many southern and eastern European countries, in parts of Africa and the Middle East, and in North America. The highest estimated mortality is in Egypt, where rates are more than three times greater than the highest rates in Europe and eight times those in the USA. In the USA, the incidence in whites is higher than in blacks. In general, in Western countries, incidence rates have been rising, but the increase has slowed or stopped in many. Mortality rates are, for the most part, decreasing. Trends are more variable in developing countries. To some extent, the geography and time trends are related to prevalence of known risk factors, especially exposure to tobacco (responsible for almost one-third of bladder cancer deaths) and, in some specific areas, schistosomiasis.

Integrity signals

Registry

Crossref · 10.1080/03008880802285032

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,710
Self-citation
TNM Classification of Malignant Tumours
Hermanek, P., & Sobin, L. H. (1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,077
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,968
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Self-citation
Global Burden of Disease and Risk Factors
López, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. T., & Murray, C. J. L. (2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,714
Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program
Hayat, M. J., Howlader, N., Reichman, M. E., & Edwards, B. K. (2007) · The Oncologist · doi:10.1634/theoncologist.12-1-20 · Cited by 1,097
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
Sant, M., Aareleid, T., Berrino, F., Lasota, M. B., Carli, P., Faivre, J., Grosclaude, P., Hédelin, G., Matsuda, T., Møller, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg754 · Cited by 1,010

Show all 40 references

Research works printed but not linked: 15

Parkin DM, 1994, Comparability and quality control in cancer registration. IARC Technical Report No 19
World Health Organization, Table 3: Estimated completeness of mortality data for latest year
Puffer RR, 1967, Patterns of urban mortality. Scientific Publication No 151
Ferlay J, 2004, IARC Cancer Base No 5
Curado MP, 2007, IARC Scientific Publications No 160
Parkin D, 2005, IARC CancerBase No 7
World Health Organization, Mortality database
Karim-Kos HE, Eur J Cancer Feb 13, 2008 (epub ahead of print)
2004, Tobacco smoke and involuntary smoking, 83
La Vecchia C, 1999, IARC Sci Publ, 139
Blot WJ, 1978, J Natl Cancer Inst, 61, 1017
1994, Schistosomes, liver flukes and Helicobacter pylori, 61
Utroska JA, 1989, An estimate of global needs for praziquantel within schistosomiasis control programmes. WHO/SCHISTO/89.102
Miller BA, 1996, NIH Publication No 96-4104
Yu MC, 1995, Cancer Epidemiol Biomarkers Prev, 4, 861

Sorted by citations

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 27,235
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017) · European Urology · doi:10.1016/j.eururo.2016.06.010 · Cited by 2,514
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
Hotez, P. J., & Kamath, A. M. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000412 · Cited by 1,269
The present and future burden of urinary bladder cancer in the world
Ploeg, M., Aben, K. K. H., & Kiemeney, L. A. L. M. (2009) · World Journal of Urology · doi:10.1007/s00345-009-0383-3 · Cited by 936
Bladder cancer
Şanlı, Ö., Dobruch, J. T., Knowles, M. A., Burger, M., Mehrdad Alemozaffar, A., Nielsen, M. E., & Lotan, Y. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.22 · Cited by 825
Arsenic exposure: A public health problem leading to several cancers
Lara, I. P., Castillo, M. M., Quintana-Pérez, J. C., Arellano-Mendoza, M. G., Cach, F. T., Valenzuela, O. L., García-Montalvo, E. A., & Hernández‐Zavala, A. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104539 · Cited by 494
Cancer burden in Africa and opportunities for prevention
Jemal, A., Bray, F., Forman, D., O’Brien, M., Ferlay, J., & Parkin, D. M. (2012) · Cancer · doi:10.1002/cncr.27410 · Cited by 473
Self-citation
International Variations in Bladder Cancer Incidence and Mortality
Chavan, S., Bray, F., Lortet‐Tieulent, J., Goodman, M. M., & Jemal, A. (2013) · European Urology · doi:10.1016/j.eururo.2013.10.001 · Cited by 349
Toxicity of heavy metals in plants and animals and their uptake by magnetic iron oxide nanoparticles
Rehman, A. U., Nazir, S., Irshad, R., Tahir, K., Rehman, K. U., Islam, R. U., & Wahab, Z. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.114455 · Cited by 336
Cancer in Africa 2012
Parkin, D. M., Bray, F., Ferlay, J., & Jemal, A. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0281 · Cited by 298
Self-citation
Plasma MiR-21
Kanaan, Z. M., Rai, S. N., Eichenberger, M. R., Roberts, H., Keskey, B., Pan, J., & Galandiuk, S. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318265bd6f · Cited by 273
Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence
Saint‐Jacques, N., Parker, L., Brown, P., & Dummer, T. (2014) · Environmental Health · doi:10.1186/1476-069x-13-44 · Cited by 238
Bladder cancer: translating molecular genetic insights into clinical practice
Liang Cheng, C., Zhang, S., MacLennan, G. T., Williamson, S. R., Antonio Lopez-beltran, B., & Montironi, R. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.07.007 · Cited by 198
A Plasma MicroRNA Panel for Detection of Colorectal Adenomas
Kanaan, Z. M., Roberts, H., Eichenberger, M. R., Billeter, A. T., Ocheretner, G., Pan, J., Rai, S. N., Jorden, J., Williford, A., & Galandiuk, S. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a15bcc · Cited by 194
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
Kiemeney, L. A. L. M., Sulem, P., Besenbacher, S., Vermeulen, S. H. H. M., Sigurðsson, Á., Þorleifsson, G., Gudbjartsson, D. F., Stacey, S., Guðmundsson, J., Zanon, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.558 · Cited by 190
Intravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analyses
Shelley, M. D., Mason, M. D., & Kynaston, H. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.12.005 · Cited by 171
Implications of LINE1 Methylation for Bladder Cancer Risk in Women
Wilhelm-Benartzi, C. S., Kelsey, K. T., Butler, R. A., Plaza, S., Gagne, L. A., Zens, M. S., Andrew, A. S., Morris, S., Nelson, H. H., Schned, A. R., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2983 · Cited by 170
What will work: fighting climate change with renewable energy, not nuclear power
(2012) · Choice Reviews Online · doi:10.5860/choice.49-6310 · Cited by 162
Intravesical gemcitabine therapy for non‐muscle invasive bladder cancer (NMIBC): a systematic review
Shelley, M. D., Jones, G., Cleves, A., Wilt, T. J., Mason, M. D., & Kynaston, H. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10880.x · Cited by 136
A Double-Blind Randomized Controlled Clinical Trial to Assess the Effect of Doppler Optimized Intraoperative Fluid Management on Outcome Following Radical Cystectomy
Pillai, P. L., McEleavy, I., Gaughan, M., Snowden, C. P., Nesbitt, I., Durkan, G. C., Johnson, M. I., Cosgrove, J. F., & Thorpe, A. C. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.07.093 · Cited by 133
A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer
Zaghloul, M. S., Boutrus, R. R., Hossieny, H. A. E., Kader, Y. A., Elattar, I. A., & Nazmy, M. S. (2010) · International Journal of Clinical Oncology · doi:10.1007/s10147-010-0074-5 · Cited by 130
DNA Methylation Array Analysis Identifies Profiles of Blood-Derived DNA Methylation Associated With Bladder Cancer
Marsit, C. J., Koestler, D. C., Christensen, B. C., Karagas, M. R., Houseman, E. A., & Kelsey, K. T. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3577 · Cited by 128
FTIR spectroscopy of biofluids revisited: an automated approach to spectral biomarker identification
Ollesch, J., Drees, S. L., Heise, H. M., Behrens, T., Brüning, T., & Gerwert, K. B. (2013) · The Analyst · doi:10.1039/c3an00337j · Cited by 119
Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019
Safiri, S., Kolahi, A., & Naghavi, M. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004128 · Cited by 113
Profilin 1 is a Potential Biomarker for Bladder Cancer Aggressiveness
Zoidakis, J., Makridakis, M., Zerefos, P. G., Bitsika, V., Esteban, S., Frantzi, M., STRAVODIMOS, K. G., Anagnou, N. P., Roubelakis, M. G., Sänchez‐Carbayo, M., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.009449 · Cited by 108
Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer
Morikawa, T., Maeda, D., Kume, H., Homma, Y., & Fukayama, M. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03725.x · Cited by 103
Cadmium as a possible cause of bladder cancer: a review of accumulated evidence
Feki-Tounsi, M., & Hamza‐Chaffai, A. (2014) · Environmental Science and Pollution Research · doi:10.1007/s11356-014-2970-0 · Cited by 92
It's in your blood: spectral biomarker candidates for urinary bladder cancer from automated FTIR spectroscopy
Ollesch, J., Heinze, M., Heise, H. M., Behrens, T., Brüning, T., & Gerwert, K. B. (2014) · Journal of Biophotonics · doi:10.1002/jbio.201300163 · Cited by 93
Intravesical gemcitabine for non-muscle invasive bladder cancer
Jones, G., Cleves, A., Wilt, T. J., MASON, M. D., Kynaston, H., & Shelley, M. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009294.pub2 · Cited by 88
Bilharzia: Pathology, Diagnosis, Management and Control
Olveda, D. U. (2013) · Tropical Medicine & Surgery · doi:10.4172/2329-9088.1000135 · Cited by 88
PREVALENCE AND RISK FACTORS OF SCHISTOSOMIASIS AMONG HAUSA COMMUNITIES IN KANO STATE, NIGERIA
Dawaki, S. S., Al‐Mekhlafi, H. M., Ithoi, I., Ibrahim, J., Abdulsalam, A. M., Ahmed, A., Sady, H., Atroosh, W. M. M., Al‐Areeqi, M. A., Elyana, F. N., et al. (2016) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946201658054 · Cited by 98
Urothelial Tumors of the Bladder
Wood, D. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00080-3 · Cited by 88
Androgen Receptor Is a Potential Therapeutic Target for Bladder Cancer
Wu, J., Han, B., Yu, S., Wang, H., & Xia, S. (2010) · Urology · doi:10.1016/j.urology.2009.10.041 · Cited by 86
Fruit and Vegetable Intakes Are Associated with Lower Risk of Bladder Cancer among Women in the Multiethnic Cohort Study1,2
Park, S., Ollberding, N. J., Woolcott, C. G., Wilkens, L. R., Henderson, B. E., & Kolonel, L. N. (2013) · Journal of Nutrition · doi:10.3945/jn.113.174920 · Cited by 83
LINE‐1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese
Cash, H. L., Tao, L., Yuan, J., Marsit, C. J., Houseman, E. A., Xiang, Y., Gao, Y., Nelson, H. H., & Kelsey, K. T. (2011) · International Journal of Cancer · doi:10.1002/ijc.26098 · Cited by 81
Racial differences in Urinary Bladder Cancer in the United States
Wang, Y., Chang, Q., & Li, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-29987-2 · Cited by 80
Recurrence, Progression, and Follow-Up in Non–Muscle-Invasive Bladder Cancer
van der Heijden, A. G., & Witjes, J. A. (2009) · European Urology Supplements · doi:10.1016/j.eursup.2009.06.010 · Cited by 77
The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis
Yu, Y., Luo, C., Feng, R., & Bi, S. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0959-8 · Cited by 75
Mouse orthotopic models for bladder cancer research
Chan, E., Patel, A. R., Heston, W. D. W., & Larchian, W. A. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08577.x · Cited by 73
Genetic variants in urinary bladder cancer: collective power of the “wimp SNPs”
Golka, K., Selinski, S., Lehmann, M., Blaszkewicz, M., Marchan, R., Ickstadt, K., Schwender, H. R., Bolt, H. M., & Hengstler, J. G. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0676-3 · Cited by 71
Combretastatin A‐4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model
Shen, C., Shee, J., Wu, J., Lin, Y., Wu, J., & Liu, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00861.x · Cited by 72
Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma
Jin, B., Fu, G., Pan, H., Cheng, X., Zhou, L., Lv, J., Chen, G., & Zheng, S. (2010) · Medical Oncology · doi:10.1007/s12032-010-9662-5 · Cited by 65
Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer
Ming-shan, L., Liu, Y., Zhang, X., Liu, J., & Wang, P. (2018) · Gene · doi:10.1016/j.gene.2018.07.041 · Cited by 63
A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
Matuszczak, M., Kiljańczyk, A., & Salagierski, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158597 · Cited by 62
Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways
Shin, D. Y., Kim, G., Hwang, H. J., Kim, W., & Choi, Y. H. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.11.002 · Cited by 62
Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population
Mittal, R. D., Mandal, R. K., & Gangwar, R. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.10.002 · Cited by 62
Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer
Gaisa, N. T., Braunschweig, T. A., Reimer, N., Bornemann, J., Eltze, E., Siegert, S. I., Toma, M. I., Villa, L., Hartmann, A., & Knuechel, R. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-1017-2 · Cited by 61
MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.
Zhao, X., He, W., Li, J., Huang, S., Wan, X., Luo, H., & Wu, D. (2015) · PubMed Central · Cited by 60
Serum Vitamin D and Risk of Bladder Cancer
Mondul, A. M., Weinstein, S. J., Männistö, S., Snyder, K., Horst, R. L., Virtamo, J. R. K., & Albanes, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0985 · Cited by 59
Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma – FISHing for the Right Catch
Bubendorf, L. (2011) · Acta Cytologica · doi:10.1159/000323652 · Cited by 59
ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis
Zhu, J., Li, Y., Tian, Z., Hua, X., Gu, J., Li, J., Liu, C., Jin, H., Wang, Y., Jiang, G., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.04.012 · Cited by 59
Emerging Roles of Cadmium and Heme Oxygenase in Type-2 Diabetes and Cancer Susceptibility
Satarug, S., & Moore, M. R. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.228.267 · Cited by 58
Pitfalls in the Use of Smoothelin to Identify Muscularis Propria Invasion by Urothelial Carcinoma
Miyamoto, H., Sharma, R. B., Illei, P. B., & Epstein, J. I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ce5066 · Cited by 56
The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer
Lei, C., Wang, W., Zhu, Y., Fang, W., & Tan, W. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.11.011 · Cited by 56
Sociocultural and environmental influences on bladder health
Palmer, M. H., Athanasopoulos, A., Lee, K.-S., Takeda, M., & Wyndaele, J. (2012) · International Journal of Clinical Practice · doi:10.1111/ijcp.12029 · Cited by 54
The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette–Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder
Rosevear, H. M., Lightfoot, A. J., O’Donnell, M. A., & Griffith, T. S. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9195-6 · Cited by 54
Bladder Cancer-associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer
Moreira, J. M. A., Ohlsson, G., Gromov, P., Simon, R., Sauter, G., Celis, J. E., & Gromova, I. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900294-mcp200 · Cited by 53
Diagnostic accuracy of urine filtration and dipstick tests for Schistosoma haematobium infection in a lightly infected population of Ghanaian schoolchildren
Kosinski, K. C., Bosompem, K. M., Stadecker, M. J., Wagner, A. D., Plummer, J. D., Durant, J. L., & Gute, D. M. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2011.02.006 · Cited by 52
MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer.
Zhao, X., Li, J., Huang, S., Wan, X., Luo, H., & Wu, D. (2015) · Europe PMC (PubMed Central) · Cited by 52
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Miranda‐Filho, A., Briganti, A., Jemal, A., & Bray, F. (2025) · European Urology · doi:10.1016/j.eururo.2025.12.011 · Cited by 51
Impaired cardiopulmonary reserve in an elderly population is related to postoperative morbidity and length of hospital stay after radical cystectomy
Prentis, J. M., Trenell, M. I., Vasdev, N., French, R., Dines, G., Thorpe, A. C., & Snowden, C. P. (2013) · British Journal of Urology · doi:10.1111/bju.12219 · Cited by 51
Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β
Gerhardt, D., Bertola, G. Z., Dietrich, F., Figueiró, F., Zanotto‐Filho, A., Fonseca, J. C. M., Morrone, F. B., Barrios, C. H., Battastini, A. M. O., & Salbego, C. G. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.02.012 · Cited by 51
Alterations of Antioxidant Enzymes and Biomarkers of Nitro-oxidative Stress in Tissues of Bladder Cancer
Islam, M. O., Bacchetti, T., & Ferretti, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2730896 · Cited by 51
Anti-tumor effect of Radix Paeoniae Rubra extract on mice bladder tumors using intravesical therapy
Lin, M., Chiang, S., Li, Y., Chen, M., Chen, Y.-S., Wu, J., & Liu, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4698 · Cited by 49
Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers
Köhler, C. U., Bryk, O., Meier, S., Lang, K., Rozynek, P., Brüning, T., & Käfferlein, H. U. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.021 · Cited by 49
EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides
Carlsson, J., Wester, K., Torre, M. D. L., Malmström, P., & Gårdmark, T. (2014) · Radiology and Oncology · doi:10.2478/raon-2014-0015 · Cited by 48
Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer
Smith, S. G., Koppolu, B., Ravindranathan, S., Kurtz, S. L., Yang, L., Katz, M. D., & Zaharoff, D. A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1672-x · Cited by 48
Bladder cancer
Bischoff, C. J., & Clark, P. E. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328329f184 · Cited by 48
Genetic polymorphisms in matrix metalloproteinases ( MMPs ) and tissue inhibitors of MPs ( TIMPs ), and bladder cancer susceptibility
Wieczorek, E., Reszka, E., Jabłonowski, Z., Jabłońska, E., Król, M. B., Grzegorczyk, A., Gromadzińska, J., Sosnowski, M., & Wąsowicz, W. (2013) · British Journal of Urology · doi:10.1111/bju.12230 · Cited by 47
Epidermal growth factor receptor expression in urinary bladder cancer
Hedau, S. T., Naik, D. S. L., Sharma, S. B., & Ray, A. (2011) · Indian Journal of Urology · doi:10.4103/0970-1591.82839 · Cited by 47
Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy
Ahirwar, D. K., Agrahari, A., Mandhani, A., & Mittal, R. D. (2009) · Biomarkers · doi:10.1080/13547500902818246 · Cited by 47
Medical Devices for Low- and Middle-Income Countries: A Review and Directions for Development
Vasan, A., & Friend, J. (2020) · Journal of Medical Devices · doi:10.1115/1.4045910 · Cited by 46
Inhibition of Autophagy Potentiates Atorvastatin-Induced Apoptotic Cell Death in Human Bladder Cancer Cells in Vitro
Kang, M., Jeong, C. W., Ku, J. H., Kwak, C. H., & Kim, H. C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058106 · Cited by 46
Molecular targets and targeted therapies in bladder cancer management
Youssef, R. F., Mitra, A. P., Bartsch, G. C., Jones, P. A., Skinner, D. G., & Côté, R. J. (2008) · World Journal of Urology · doi:10.1007/s00345-008-0357-x · Cited by 46
miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1
Liu, J., Cao, J., & Zhao, X. (2015) · BMC Urology · doi:10.1186/s12894-015-0028-3 · Cited by 45
Association of secondhand smoke exposures with DNA methylation in bladder carcinomas
Wilhelm-Benartzi, C. S., Christensen, B. C., Koestler, D. C., Houseman, E. A., Schned, A. R., Karagas, M. R., Kelsey, K. T., & Marsit, C. J. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9788-6 · Cited by 44
Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de‐differentiation
Samaratunga, H., Delahunt, B., Egevad, L., Adamson, M., Hussey, D., Malone, G., Hoyle, K., Nathan, T., Kerle, D., Ferguson, P. M., et al. (2015) · Histopathology · doi:10.1111/his.12785 · Cited by 44
Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project)
Roobol, M. J., Bangma, C. H., Bouazzaoui, S. E., Franken-Raab, C. G. A. M., & Zwarthoff, E. C. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.12.002 · Cited by 43
Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk
Lehmann, M., Selinski, S., Blaszkewicz, M., Orlich, M. M., Ovsiannikov, D., Moormann, O., Guballa, C., Kress, A., Truß, M. C., Gerullis, H., et al. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0617-6 · Cited by 42
The prognostic value of histological subtype in patients with metastatic bladder cancer
Chen, C., Hu, L., Chen, Y., & Hou, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16083 · Cited by 42
CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach
Anand, V., Khandelwal, M., Appunni, S., Gupta, N., Seth, A., Singh, P., Mathur, S. R., & Sharma, A. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03024-9 · Cited by 42
Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: A systematic review and network meta-analysis
Zhao, Y., Chen, C., Pan, W., Gao, M., He, W., Mao, R., Lin, T., & Huang, J. (2015) · Nutrition · doi:10.1016/j.nut.2015.10.023 · Cited by 40
Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer
Yang, X., Zhao, L., Li, M., Lei, Y., Zhang, S., Mi, Z., Ren, L., & Xu, J. (2018) · Scientific Reports · doi:10.1038/s41598-017-19026-x · Cited by 41
Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case–control and cohort studies
Akhtar, S., AlShammari, A. M., & Al-Abkal, J. (2018) · World Journal of Urology · doi:10.1007/s00345-018-2206-x · Cited by 41
Hypermethylation of Genes Detected in Urine from Ghanaian Adults with Bladder Pathology Associated with Schistosoma haematobium Infection
Zhong, X., Isharwal, S., Naples, J. M., Shiff, C., Veltri, R. W., Shao, C., Bosompem, K. M., Sidransky, D., & Hoque, M. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059089 · Cited by 41
BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells
Chiu (2010) · International Journal of Oncology · doi:10.3892/ijo_00000633 · Cited by 40
Epigenetic repression of regulator of G‐protein signaling 2 by ubiquitin‐like with PHD and ring‐finger domain 1 promotes bladder cancer progression
Liang, Y. J., Lin, J., Qiu, F., Cao, M., Chen, H., Liu, Z., & Huang, Y. (2014) · FEBS Journal · doi:10.1111/febs.13116 · Cited by 39
Human papillomaviruses in urological malignancies: A critical assessment
Tolstov, Y. L., Hadaschik, B. A., Pahernik, S. A., Hohenfellner, M., & Duensing, S. M. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.06.012 · Cited by 39
Bladder Cancer Risk Associated with Genotypic Polymorphism of the Matrix Metalloproteinase-1 and 7 in North Indian Population
Srivastava, P., Gangwar, R., Kapoor, R., & Mittal, R. D. (2010) · Disease Markers · doi:10.1155/2010/149651 · Cited by 39
Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing
Chen, Y., Wang, S., Wu, X., Shen, M., Chen, Z., Chen, X., Liu, Y.-X., Zhu, X., Guo, F., Duan, X., et al. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.11.007 · Cited by 38
Dietary patterns and risk of bladder cancer: a systematic review and meta-analysis
Dianatinasab, M., Forozani, E., Akbari, A., Azmi, N., Bastam, D., Fararouei, M., Wesselius, A., & Zeegres, M. P. (2022) · BMC Public Health · doi:10.1186/s12889-022-12516-2 · Cited by 40
Bladder cancer mortality trends and patterns in Córdoba, Argentina (1986–2006)
Pou, S. A., Osella, A. R., & Dı́az, M. D. P. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9711-6 · Cited by 37
Updates in intravesical electromotive drug administration® of mitomycin-C for non-muscle invasive bladder cancer
Stasi, S. M. D., & RIEDL, C. R. (2009) · World Journal of Urology · doi:10.1007/s00345-009-0389-x · Cited by 36
DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer
Wilhelm-Benartzi, C. S., Koestler, D. C., Houseman, E. A., Christensen, B. C., Wiencke, J. K., Schned, A. R., Karagas, M. R., Kelsey, K. T., & Marsit, C. J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq178 · Cited by 34
International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics
Goossens, M. E., Isa, F., Brinkman, M. T., Mak, D., Reulen, R. C., Wesselius, A., Benhamou, S., Bosetti, C., Bueno-de-Mesquita, B. H., Carta, A., et al. (2016) · Archives of Public Health · doi:10.1186/s13690-016-0140-1 · Cited by 35
HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma
Gosenca, D., Gabriel, U., Steidler, A., Mayer, J. M., Diem, O., Erben, P., Fabarius, A. C., Leib‐Mösch, C., Hofmann, W., & Seifarth, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049341 · Cited by 33
Zoledronic acid inhibits the pentose phosphate pathway through attenuating the Ras-TAp73-G6PD axis in bladder cancer cells
Wang, X., Wu, G. J., Cao, G., Yang, L., Xu, H., Huang, J. J., & Hou, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3995 · Cited by 33
CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
Hegele, A., Mecklenburg, V., Varga, Z., Olbert, P. J., Hofmann, R. W., & Barth, P. J. (2010) · PubMed · Cited by 33

Authors: Parkin, D. M.
Affiliations: University of Oxford (GB)
Corresponding author: Parkin, D. Maxwell
ORCID: Parkin, D. Maxwell
Venue: Scandinavian Journal of Urology and Nephrology
Publisher: Informa UK Limited
Published: 2008-01-01
Volume: 42
Issue: sup218
Pages: 12-20
ISSN: 0036-5599 (ISSN-L)
1651-2065
DOI: 10.1080/03008880802285032
OpenAlex: W2117705442
Cited by: 357
References: 40
Citations by year: 2026: 2 · 2025: 8 · 2024: 9 · 2023: 8 · 2022: 18 · 2021: 16 · 2020: 10 · 2019: 14 · 2018: 16 · 2017: 29 · 2016: 24 · 2015: 25 · 2014: 31 · 2013: 33 · 2012: 33
FWCI: 4.57
Type: journal article
Language: en
Open access: closed
Locations: Scandinavian Journal of Urology and Nephrology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Surgery › Urinary and Genital Oncology Studies
Keywords: bladder cancer, global burden of disease, cancer incidence, cancer mortality, incidence trends, mortality trends, sex differences, regional variation, tobacco smoke exposure, schistosomiasis, risk factors, non-invasive bladder cancer
MeSH terms: Urinary Bladder Neoplasms, Humans, Morbidity, Risk Factors, Global Health, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The global burden of urinary bladder cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks